Search details
1.
Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer's disease.
J Neuroinflammation
; 20(1): 177, 2023 Jul 28.
Article
in English
| MEDLINE | ID: mdl-37507761
2.
Therapeutic development of polymers for prion disease.
Cell Tissue Res
; 392(1): 349-365, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-35307792
3.
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints.
Nucleic Acids Res
; 48(19): 10615-10631, 2020 11 04.
Article
in English
| MEDLINE | ID: mdl-32776089
4.
Polymorphisms in glia maturation factor ß gene are markers of cellulose ether effectiveness in prion-infected mice.
Biochem Biophys Res Commun
; 560: 105-111, 2021 06 30.
Article
in English
| MEDLINE | ID: mdl-33984767
5.
Cellulose ether treatment in vivo generates chronic wasting disease prions with reduced protease resistance and delayed disease progression.
J Neurochem
; 152(6): 727-740, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31553058
6.
Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.
J Virol
; 91(6)2017 03 15.
Article
in English
| MEDLINE | ID: mdl-28077650
7.
A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents.
PLoS Pathog
; 12(12): e1006045, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27973536
8.
Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells.
Biochem Biophys Res Commun
; 460(4): 989-95, 2015 May 15.
Article
in English
| MEDLINE | ID: mdl-25839661
9.
Efficacy and mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells: implications of interferon and phosphodiesterase 4D-interacting protein.
J Virol
; 88(8): 4083-99, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24453367
10.
Improvement of anti-prion efficacy with stearoxy conjugation of hydroxypropyl methylcellulose in prion-infected mice.
Carbohydr Polym
; 337: 122163, 2024 Aug 01.
Article
in English
| MEDLINE | ID: mdl-38710557
11.
Combination of Styrylbenzoazole Compound and Hydroxypropyl Methylcellulose Enhances Therapeutic Effect in Prion-Infected Mice.
Mol Neurobiol
; 2023 Dec 20.
Article
in English
| MEDLINE | ID: mdl-38114760
12.
Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion.
Neuropathology
; 32(2): 124-32, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-21801238
13.
Activities of curcumin-related compounds in two cell lines persistently infected with different prion strains.
Biochim Biophys Acta Gen Subj
; 1866(4): 130094, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35065183
14.
Anti-prion activity of cellulose ether is impaired in mice lacking pre T-cell antigen receptor α, T-cell receptor δ, or lytic granule function.
Int Immunopharmacol
; 107: 108672, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35279511
15.
Anti-prion activity of protein-bound polysaccharide K in prion-infected cells and animals.
Biochem Biophys Res Commun
; 405(2): 285-90, 2011 Feb 11.
Article
in English
| MEDLINE | ID: mdl-21219866
16.
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics.
Mol Neurobiol
; 58(9): 4280-4292, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-33983547
17.
In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.
Eur J Nucl Med Mol Imaging
; 37(5): 934-41, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20016895
18.
Autoantibody to glial fibrillary acidic protein in the sera of cattle with bovine spongiform encephalopathy.
Proteomics
; 9(16): 4029-35, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19658106
19.
Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases.
Neuropathology
; 29(5): 632-6, 2009 Oct.
Article
in English
| MEDLINE | ID: mdl-19788637
20.
[Innovation of therapeutics and prophylaxis for prion diseases].
Rinsho Shinkeigaku
; 49(11): 946-8, 2009 Nov.
Article
in Japanese
| MEDLINE | ID: mdl-20030256